Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

TransPharma Medical

Request full access

Specialty pharmaceutical company focused on the development and commercialization of drug-products

Kochav Yair, IsraelFounded 2000Biotechnology

About TransPharma Medical

Established in 2000, TransPharma Medical Ltd. was a specialty pharmaceutical company headquartered in Lod, Israel, that concentrated on creating and marketing drug products using its active transdermal drug delivery technology. The company's business model revolved around forming strategic partnerships with major pharmaceutical firms and pursuing independent product development to bring multiple drug products to market.

The core of TransPharma Medical's offering was the ViaDerm system, a technology designed for the transdermal delivery of medications. This system utilized a handheld, reusable electronic device that employed radiofrequency energy to create microscopic channels (RF-MicroChannels) in the skin's outer layer. This process enabled the subsequent delivery of a broad range of drugs, including hydrophilic small molecules, peptides, and proteins, through a specialized patch applied to the treated area. The medication would then passively diffuse through these microchannels into the bloodstream. The ViaDerm system, which received CE Mark approval, was developed for both self-administered home use and in-office applications, designed to be a virtually painless and easy-to-use alternative to injections.

Throughout its operation, TransPharma Medical successfully raised capital to fund its research and development. The company secured a total of $33.4 million in funding from investors, including Evergreen Venture Partners, Pitango Venture Capital, Teva Pharmaceuticals, and SCP Vitalife Partners. Its clinical pipeline included a product for osteoporosis, developed in collaboration with Eli Lilly, which advanced to Phase 2b studies, as well as a GLP-1 agonist for type II diabetes. A significant milestone was the successful completion of a Phase 1 trial for its self-applied ViaDerm system. In March 2012, Syneron Medical Ltd. (later acquired by Candela Medical) acquired substantially all of TransPharma Medical's assets, including its extensive patent portfolio, for approximately $3.6 million.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
34
Open positions
None listed
Dealroom signal
19.3/100

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Mar 2012 $0 — Syneron Medical —
SERIES C✓Equity / VC Jul 2006 $18M $72M T2C2 Capital · Argonaut Private Equity · Pitango Venture Capital · Agronaut Private Equity —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

TransPharma Medical website traffic

Latest recorded traffic for TransPharma Medical is 260 monthly website visits, up 225% over the last three months. TransPharma Medical's team grew 0% over the past year.

Latest monthly visits260 3-month web change+225% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

TransPharma Medical in the Kochav Yair ecosystem

Live from Dealroom

The TransPharma Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Series B and later3 investors entered at this stage

  • Agronaut Private Equity
  • T2C2 Capital
  • Argonaut Private Equity

Other known investors1 additional known investor

  • Syneron Medical
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇿🇦 South Africa84.6%
🇮🇱 Israel7.7%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about TransPharma Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See TransPharma Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.